CANCvsBBPETF Comparison
Tema Oncology ETF (CANC) and Virtus LifeSci Biotech Products ETF (BBP) belong to the same industry segment: Tomorrow's Treatments. In contrast, BBP's top sector exposures are Healthcare. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.34% for BBP. CANC is up 19.12% year-to-date (YTD) with +$67M in YTD flows. BBP performs better with 28.1% YTD performance, and +$66M in YTD flows. Run a side-by-side ETF comparison of CANC and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs BBP performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC BBP | -0.39%-2.17% | -0.13%+5.26% | +19.12%+28.10% | +38.72%+41.42% | +95.73%+121.19% | n/a+99.68% |
| Flows | CANC BBP | +$5M+$5M | +$14M+$26M | +$67M+$66M | +$85M+$78M | +$151M+$83M | -+$76M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC BBP | +23.58%+28.19% | +23.29%+26.47% | +22.45%+25.00% | n/a+26.86% |
| Max drawdown | CANC BBP | -13.09%-8.70% | -13.09%-9.59% | -27.90%-25.54% | n/a-37.61% |
| Max drawdown duration | CANC BBP | 59d65d | 59d48d | 441d292d | n/a586d |
CANC | BBP | |
Last sale 10/26/2026 at 1:30 PM | $40.99 | $102.33 |
| Previous close 10/23/2026 | $41.29 | $102.07 |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
CANC | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
CANC | BBP | |
|---|---|---|
| Last price | $40.99 | $102.33 |
| 1D performance | -0.73% | +0.26% |
| AuM | $210.84 M | $127.72 M |
| E/R | 0.99% | 0.34% |
CANC | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Tema | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | - | 66 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | August 15, 2023 | December 16, 2014 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
